NAGE FY 2017 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M-2.1% YoY

Gross Profit

$10M49.4% margin

Operating Income

-$16M-77.2% margin

Net Income

-$11M-53.7% margin

EPS (Diluted)

$-0.26

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$63M

Total Liabilities

$9M

Stockholders' Equity

$54M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$22M	-2.1%
Gross Profit	$10M	$10M	+0.8%
Operating Income	-$16M	-$3M	-463.7%
Net Income	-$11M	-$3M	-288.6%